Jim Martineau

Bio:

Jim is Co-founder/CEO of Nosis Bio, a precision medicine company pioneering cell-targeted RNA medicines. Prior to founding Nosis, Jim was Head of Oncology Products at Natera and previously, led product teams at Roche and Flatiron Health focused on clinico-genomics precision medicine products. Jim has an MBA from Wharton in Healthcare Management, MSc in Computational Math from Stanford, and a BSc in Physics from CSM.